DAVID DAY: Open Payments
NPI 1114067436 · WAKEENEY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$272 in 14 payments from 9 companies in 2025. Trend: 2023 $335 · 2024 $312 · 2025 $272
Food & beverage: $272
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $78 |
| Otsuka America Pharmaceutical, Inc. | 2 | $58 |
| CSL Behring | 1 | $35 |
| ABBVIE INC. | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Viatris Specialty LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
Products named: EVENITY, REXULTI, Andembry, VRAYLAR, RELISTOR, YUPELRI, AIRSUPRA, JARDIANCE.
Industry payments across KS — which companies pay providers there.
